Skip to content
Research Article Open access CC BY 4.0

The Impacts of Gianotti-Crosti Syndrome (Papular Acrodermatitis of Childhood) on the Quality of Life of Children

Antonio Chuh

International Journal of TROPICAL DISEASE & Health · pp. 1–7 · Published 30 Mar 2016

10.9734/IJTDH/2016/25125

Abstract

Background: Gianotti-Crosti syndrome (GCS) is a self-remitting eruption related to viral infections. Ribavirin has been reported to be effective in treating severe GCS. Before clinical trials on antiviral agents, the magnitude of GCS affecting the quality of life in children should be ascertained. Aim: To investigate the impact of GCS on the QOL of children. Methods: Our setting was a teaching clinic. We validly translated the Children Dermatology Life Quality Index into Chinese. We recruited all children aged five to 16 years diagnosed with GCS over two years. For each child with GCS, we recruited the next age-and-sex pair-matched child consulting us for atopic dermatitis (AD), and the next age-and-sex pair-matched child brought to consult us for problems unrelated to the skin as controls. All study and control subjects completed the CDLQI. Results: 23 children were GCS and 46 children as controls were recruited. The impacts of GCS on children were significantly higher than children brought to consult us for problems unrelated to the skin (P < 0.05), with the parameters symptoms and feelings, leisure, school or holidays, and treatment mostly affected.  However, the scores were low. Four (17%) study subjects and none (0%) in the second control had total CDLQI higher than 30%. The difference is insignificant (RR: inapplicable; P = 0.11). Impacts of AD on children were significantly higher than such for GCS (P < 0.001). Twelve (52%) children with AD and four (17%) children with GCS had total scores higher than 30% (RR: 3.00, 95% CI: 1.13 – 7.94; P < 0.05). When compared to a similar study on children with pityriasis rosea, the impacts of GCS were very similar to those of pityriasis rosea. Conclusion: GCS casts relatively low impacts on the QOL of children. These impacts were much lower than such of AD.

Children dermatology life quality index Chinese children dermatology life quality index paraviral exanthema Chuh and Zawar’s classification of Gianotti-Crosti syndrome Chuh and Zawar’s diagnostic criteria of Gianotti-Crosti syndrome

References (26)

  1. 1 The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis.. [DOI]
  2. 2 The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use [DOI]
  3. 3 The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation [DOI]
  4. 4 Quality of Life in Patients with Atopic Dermatitis: Disease Burden, Measurement, and Treatment Benefit [DOI]
  5. 5 The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis II. Observer variation of clinical diagnosis and signs of atopic dermatitis [DOI]
  6. 6 Use of high-dose acyclovir in pityriasis rosea [DOI]
  7. 7 Gianotti-Crosti syndrome: a study of 26 cases [DOI]
  8. 8 Does age or gender influence quality of life in children with atopic dermatitis? [DOI]
  9. 9 Interventions for pityriasis rosea [DOI]
  10. 10 Diagnostic criteria for Gianotti-Crosti syndrome: a prospective case-control study for validity assessment.
  11. 11 Low dose of acyclovir may be an effective treatment against pityriasis rosea: a random investigator-blind clinical trial on 64 patients [DOI]
  12. 12 A Prospective Case Control Study of the Association of Gianotti–Crosti Syndrome with Human Herpesvirus 6 and Human Herpesvirus 7 Infections [DOI]
  13. 13 Pityriasis Rosea in Children: Clinical Features and Laboratory Investigations [DOI]
  14. 14 An International Multi-center Study on Self-assessed and Family Quality of Life in Children with Atopic Dermatitis.
  15. 15 Relapsing Pityriasis Rosea [DOI]
  16. 16 The Diagnostic Criteria of Gianotti‐Crosti Syndrome: Are They Applicable to Children in India? [DOI]
  17. 17 Validation of a Cantonese Version of the Children's Dermatology Life Quality Index [DOI]
  18. 18 A Randomized, Double-blind, Placebo-Controlled Study of Efficacy of Oral Acyclovir in the Treatment of Pityriasis Rosea [DOI]
  19. 19 Effect on quality of life in patients with pityriasis rosea: Is it associated with rash severity? [DOI]
  20. 20 Papular acrodermatitis of childhood and other papulo-vesicular acro-located syndromes [DOI]
  21. 21 Quality of Life in Children with Pityriasis Rosea: A Prospective Case Control Study [DOI]
  22. 22 [Gianotti-Crosti's infantile papular acrodermatitis. Nosological relationship with viral hepatitis. A fatal outcome].
  23. 23 Gianotti-Crosti syndrome and Epstein-Barr virus infection [DOI]
  24. 24 The Validity and Reliability of the Thai Version of Children's Dermatology Life Quality Index (CDLQI).
  25. 25 [Infantile papular acrodermatitis. Acrodermatitis papulosa and the infantile papulovesicular acrolocalized syndrome].
  26. 26 [An association between hepatitis-B antigen-negative infantile papular acrodermatitis and Epstein-Barr virus infection].

Cited by 2

Blaschkoid Pityriasis Rosea on Trunk and Upper Limb of an Adult Male - A Case Report

M. Sivasankari, Manoj Gopal Madakshira, Vikas Pathania · Indian Journal of Postgraduate Dermatology · 2026

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.

Related research

Article metrics

Real usage data collected on this platform.

2

Page views

0

PDF downloads

0

Outbound clicks

2

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.